| Pembrolizumab plus chemotherapy in metastatic non–small-cell lung cancer L Gandhi, D Rodríguez-Abreu, S Gadgeel, E Esteban, E Felip, ... New England journal of medicine 378 (22), 2078-2092, 2018 | 5698 | 2018 |
| Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label … TSK Mok, YL Wu, I Kudaba, DM Kowalski, BC Cho, HZ Turna, G Castro, ... The Lancet 393 (10183), 1819-1830, 2019 | 2937 | 2019 |
| Pemetrexed plus platinum with or without pembrolizumab in patients with previously untreated metastatic nonsquamous NSCLC: protocol-specified final analysis from KEYNOTE-189 D Rodríguez-Abreu, SF Powell, MJ Hochmair, S Gadgeel, E Esteban, ... Annals of Oncology 32 (7), 881-895, 2021 | 348 | 2021 |
| Potential role of immunosenescence in cancer development T Fulop, R Kotb, CF Fortin, G Pawelec, F De Angelis, A Larbi Annals of the new York Academy of Sciences 1197 (1), 158-165, 2010 | 184 | 2010 |
| Aging, immunity, and cancer T Fulop, A Larbi, R Kotb, F de Angelis, G Pawelec Discovery medicine 11 (61), 537-550, 2011 | 183 | 2011 |
| Pembrolizumab plus chemotherapy in metastatic non-small-cell lung cancer F De Angelis, M Domine, P Clingan, MJ Hochmair, SF Powell, SY Cheng, ... N Engl J Med 378, 2078-92, 2018 | 78 | 2018 |
| FP13. 02 pembrolizumab+ pemetrexed-platinum vs pemetrexed-platinum for metastatic NSCLC: 4-year follow-up from KEYNOTE-189 J Gray, D Rodríguez-Abreu, SF Powell, MJ Hochmair, S Gadgeel, ... Journal of Thoracic Oncology 16 (3), S224, 2021 | 45 | 2021 |
| Abstract CT043: Outcomes among patients (pts) with metastatic nonsquamous NSCLC with liver metastases or brain metastases treated with pembrolizumab (pembro) plus pemetrexed … MC Garassino, S Gadgeel, E Esteban, E Felip, G Speranza, FD Angelis, ... Cancer Research 79 (13_Supplement), CT043-CT043, 2019 | 28 | 2019 |
| Paraneoplastic neurologic syndromes: clinical presentation and management S Martel, F De Angelis, E Lapointe, S Larue, G Speranza Current Problems in Cancer 38 (4), 115-134, 2014 | 24 | 2014 |
| Health-related quality of life (HRQoL) in the KEYNOTE-189 study of pembrolizumab (pembro) or placebo (pbo)+ pemetrexed (pem)+ platinum (plt) for metastatic NSCLC. MC Garassino, D Rodriguez-Abreu, SM Gadgeel, EE Gonzalez, E Felip, ... Journal of Clinical Oncology 36 (15_suppl), 9021-9021, 2018 | 18 | 2018 |
| P2. 07-029 CheckMate 169: safety/efficacy of Nivolumab in Canadian pretreated advanced NSCLC (including elderly and PS 2) patients R Juergens, Q Chu, J Rothenstein, F De Angelis, S Banerji, K Marquis, ... Journal of Thoracic Oncology 12 (11), S2426-S2427, 2017 | 17 | 2017 |
| KEYNOTE-189: randomized, double-blind, phase 3 study of pembrolizumab (pembro) or placebo plus pemetrexed (pem) and platinum as first-line therapy for metastatic NSCLC L Gandhi, D Rodgriguez-Abreu, S Gadgeel, E Esteban, E Felip, ... Cancer research (Chicago, Ill.), 2018 | 7 | 2018 |
| Abstract CT075: KEYNOTE-189: Randomized, double-blind, phase 3 study of pembrolizumab (pembro) or placebo plus pemetrexed (pem) and platinum as first-line therapy for … L Gandhi, D Rodgríguez-Abreu, S Gadgeel, E Esteban, E Felip, ... Cancer Research 78 (13_Supplement), CT075-CT075, 2018 | 4 | 2018 |
| PD2. 02 pembrolizumab plus pemetrexed-platinum for patients with metastatic nonsquamous NSCLC and liver or brain metastases: results from KEYNOTE-189 MC Garassino, S Gadgeel, E Esteban, E Felip, G Speranza, F De Angelis, ... Journal of Thoracic Oncology 14 (11), S1170-S1171, 2019 | 3 | 2019 |
| Abstract CT034: Results from phase 3 KEYLYNK-008: Pembrolizumab (pembro) with and without maintenance olaparib (ola) after first-line (1L) pembro plus chemotherapy (chemo) for … M Hochmair, M Schenker, MC Dols, TM Kim, SW Kim, O Ozyilkan, ... Cancer Research 84 (7_Supplement), CT034-CT034, 2024 | | 2024 |
| Real-world evidence of treatment and prognosis of older women with high-risk endometrial cancer F De Angelis, M Arès, V Vallée-Guignard, T Derashodian, ... Journal of Geriatric Oncology 14 (8), S25-S27, 2023 | | 2023 |
| Patients' perspectives and safety of COVID-19 vaccination among cancer patients: A prospective single-center study. N Daaboul, M Boutin, C Sperlich, M Fuchs, LP Haraoui, G Speranza, ... Journal of Clinical Oncology 40 (16_suppl), e24043-e24043, 2022 | | 2022 |
| REAL WORLD EFFICACY AND TOXICITY OF ANTI-PD1 TREATMENT IN ELDERLY PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) M Boutin, F De Angelis, V Éthier, G Speranza, D Berbiche Journal of Geriatric Oncology 10 (6), S42-S44, 2019 | | 2019 |
| TREATMENT AND OUTCOMES OF ELDERLY PATIENTS WITH GLIOBLASTOMA IN A REAL-LIFE SETTING M Boutin, F De Angelis, G Speranza, S Rajakesari, D Berbiche Journal of Geriatric Oncology 10 (6), S44, 2019 | | 2019 |
| P2. 04-77 Hyperprogression with Immunotherapy in Metastatic Non-Small Cell Lung Cancer: Hôpital Charles-LeMoyne Experience LG Gomez, D Gonzalez, B Samson, F De Angelis Journal of Thoracic Oncology 14 (10), S739, 2019 | | 2019 |
